#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians need to recognize that cannabis use is an independent stroke risk factor across age groups, requiring them to obtain detailed substance use histories during cardiovascular assessments in younger patients presenting with acute neurological symptoms. This evidence supports counseling patients about cerebrovascular risks associated with cannabis, particularly those with additional vascular risk factors or family history of stroke. Understanding cannabis as a modifiable stroke risk factor allows clinicians to incorporate substance-related counseling into primary and secondary stroke prevention strategies.
A Cambridge University study demonstrates that recreational cannabis use, along with cocaine and amphetamines, significantly elevates stroke risk across age groups, including in younger populations previously considered at low cardiovascular risk. The research highlights an important but often underrecognized vascular complication of cannabis use that clinicians should screen for when taking substance use histories, particularly in patients presenting with acute neurological symptoms or those with unexplained stroke in younger demographics. This finding carries implications for informed consent discussions with patients, especially young adults who may perceive cannabis as a safer alternative to other drugs or assume their age protects them from serious cardiovascular events. Clinicians should consider cannabis use as a relevant risk factor when evaluating stroke risk and may need to counsel patients more explicitly about this vascular danger. For patients with existing cardiovascular disease or stroke risk factors, use of cannabis warrants explicit discussion and documentation during clinical encounters.
“What we’re seeing in the data is that cannabis, particularly when smoked and especially in younger patients with underlying vascular risk factors, can acutely elevate blood pressure and heart rate enough to precipitate a stroke, and I’ve had to counsel several patients in their 30s and 40s about this risk after they assumed cannabis was safe because it’s legal. The key distinction I make clinically is between the plant’s relative safety profile for certain chronic conditions and its acute cardiovascular effects, which we cannot ignore just because other recreational substances carry similar risks.”
💉 Growing evidence links cannabis use to acute stroke risk, particularly concerning given increasing recreational use among younger populations with fewer traditional vascular risk factors. While the mechanistic pathways remain incompletely understood—involving potential vasospasm, thrombotic effects, and hemodynamic changes—clinicians should recognize that cannabis-associated strokes represent a distinct clinical entity that may not follow typical preventive cardiology paradigms. The challenge in clinical practice is that cannabis use remains underdetected in routine stroke workups, as patients may not spontaneously disclose recent use or may not perceive it as a modifiable risk factor. For providers managing young stroke patients without conventional risk factors, a detailed substance use history including cannabis frequency and route of administration is increasingly warranted, as this information could influence acute management decisions and secondary prevention counseling. Until we better characterize dose-response relationships and identify which patient phenotypes face highest risk, a conservative approach acknowledging cannabis as a potential
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: